A great success for the symposium dedicated to the evolution of keratoconus therapies, featuring Prof. Cosimo Mazzotta, Dr. Adel Barbara, and Dr. Marco Lombardo.
The experts retraced twenty years of scientific and clinical progress, from the origins of corneal cross-linking (CXL) to the more recent revolution in theranostics, which has finally brought order and clarity to the complex landscape of CXL techniques.
Theranostics marks the beginning of a new era in keratoconus treatment: a data-driven approach that combines molecular imaging diagnosis and real-time targeted therapy, thanks to the measurement of corneal riboflavin and its photoactivation.
A true scientific revolution that puts an end to empiricism and paves the way for precision, predictive, and truly personalized medicine.